Almost Family Announces $350 Million Credit Facility;

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Almost Family Announces $350 Million Credit Facility; Receipt of Regulatory Approvals for Acquisition

LOUISVILLE, KY, Dec. 06, 2016 (GLOBE NEWSWIRE) -- Almost Family, Inc. (Nasdaq: AFAM ), a leading regional provider of home health nursing services, announced today it has entered into a new five-year $350 million revolving credit facility that increases its financial flexibility through 2021 (the Facility).  J.P. Morgan Securities LLC acted as lead book-runner and arranger, while Bank of America, N.A. acted as joint lead arranger under the Facility which replaces the Company's previous $175 million credit facility.  The Facility includes an accordion feature which permits expansion up to $500 million.

The Company also announced that it cleared the necessary regulatory approvals for the previously announced agreement to acquire a controlling interest in the entity holding the home health and hospice assets of Community Health Systems, Inc. (NYSE: CYH ) (CHS).  CHS Home Health, a provider of skilled home health and hospice services, currently operates 74 home health and 15 hospice branch locations in 22 states.  With the completion of this transaction, Almost Family will operate 340 branches across 26 states and its annual net revenue run rate is expected to exceed the $800 million mark.  The Company expects to fund the acquisition on December 30, 2016 the last day of its fiscal year.

William Yarmuth, Chief Executive Officer, commented, “We are extremely pleased to announce this larger facility, along with having received the necessary regulatory approvals we need to close on the previously announced CHS joint-venture.  Both of these accomplishments will allow us to close on the transaction by the end of the year.  We look forward to getting this deal closed and getting started on our exciting new partnership.”

Steve Guenthner, President, added, “We are very pleased with the results of our syndication effort, providing us with a lower cost facility that now has the capacity to be as large as a half-billion dollars.  In addition to the leadership of JPMorgan in a successful syndication, we acknowledge the strong and consistent support of our existing bank group and welcome Capital One to our valuable consortium of credit providers.”

Other Matters The Company also reminded investors of the following:

  • The Company’s results of operations for the third quarter of 2016 included revenue from an annual payment of $4.3 million to its Imperium ACO-enablement subsidiary (reported in the Healthcare Innovations segment).  Under the Medicare Shared Savings ACO program, success-based revenues are recorded only once per year each third quarter, thus no additional success-based revenues, if any, will be recorded before the third quarter of 2017.
  • As previously disclosed, final FY2017 Medicare reimbursement regulations are expected to reduce our reimbursement rates for FY2017 between 1% and 2%.  Since reimbursement is determined based on the ending date of each episode, these new rates will be in effect for a portion of the episodic revenue reported during the fourth quarter of 2016.
  • The Company’s results for the fourth quarter of 2015 included new results of operations from businesses acquired in mid-third quarter 2015 (Ingenios and WillCare) and mid-fourth quarter 2015 (Blackstone).  The Company has completed no acquisitions in the third quarter of 2016 and, other than the timing of the CHS joint venture as described elsewhere in this release, the Company does not expect to complete any acquisitions in the fourth quarter of 2016.
  • Approximately 25% of the Company’s revenues are generated in the state of Florida where Hurricane Matthew created some temporary disruption in early October.
  • The Company expects to close the CHS joint venture transaction on December 30, 2016, with transfer of control of the operations to the Company at 12:01 AM December 31, 2016, which is the first day of the Company’s 2017 fiscal year.

The Company also noted that it will continue to aggressively pursue quality acquisitions of in-home healthcare service providers consistent with its stated strategy and the types of services its segments currently provide.

New Credit Facility Details The $350 million facility includes a syndicate of five banks including JPMorgan Chase Bank, as Administrative Agent, Bank of America, Fifth Third Bank and Regions Bank, all existing syndicate banks that expanded their commitments and the addition of Capital One Bank.  The Facility extends the maturity profile of our bank commitment to December 2021.  The Facility may be used for general corporate purposes including acquisitions and also contains an accordion feature to increase total commitments to $500 million.  Borrowings, other than letters of credit, under the Facility generally will bear interest at a rate varying from LIBOR rate plus 1.50% to LIBOR rate plus 2.75%, depending on leverage (0.25% lower than the previous facility).  The Facility is secured by substantially all of the Company’s assets and the stock of its subsidiaries.

About Almost Family, Inc. Almost Family, Inc., founded in 1976, is a leading regional provider of home health nursing services, with branch locations in Florida, Ohio, Tennessee, New York, Connecticut, Kentucky, New Jersey, Massachusetts, Pennsylvania, Georgia, Wisconsin, Indiana, Missouri, Illinois, Mississippi and Alabama (in order of revenue significance).  Almost Family, Inc. and its subsidiaries operate a Medicare-certified segment and a personal care segment.  Excluding the CHS joint venture, Almost Family operates 250 branch locations in sixteen U.S. states.

Forward Looking Statements All statements, other than statements of historical facts, included in this news release are forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements may be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “believe,” “estimate,” “project,” “anticipate,” “continue,” or similar terms, variations of those terms or the negative of those terms.  These forward-looking statements are based on the Company’s current plans, expectations and projections about future events.  Statements about the Company’s or CHS Home Health’s past financial results do not, and are not meant to, predict future results.  The Company can provide no assurance that such results and performance will continue.

Because forward-looking statements involve risks and uncertainties, the Company’s actual results could differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. The potential risks and uncertainties which could cause actual results to differ materially include: the satisfaction of the conditions precedent to the consummation of the proposed transaction, including, without limitation, the receipt of regulatory approvals or third party consents on the terms desired or anticipated; the Company’s ability to obtain financing on the anticipated terms and schedule; disruptions of the Company’s and CHS Home Health’s current plans, operations and relationships caused by the announcement and pendency of the proposed transaction; the impact of further changes in healthcare reimbursement systems, including the ultimate outcome of potential changes to Medicare reimbursement for home health services and to Medicaid reimbursement due to state budget shortfalls; the ability of the Company to maintain its level of operating performance and achieve its cost control objectives; changes in our relationships with referral sources; unanticipated difficulties or expenditures relating to the proposed transaction, including, without limitation, difficulties that result in the failure to achieve expected synergies, efficiencies and cost savings from the proposed transaction within the expected time period (if at all); government regulation; health care reform; pricing pressures from Medicare, Medicaid and other third-party payers; changes in laws and interpretations of laws relating to the healthcare industry; the ability of the Company to integrate, manage and keep secure our information systems; changes in the marketplace and regulatory environment for Health Risk Assessments and the Company’s self-insurance risks.  For a more complete discussion regarding these and other factors which could affect the Company’s financial performance, refer to the Company’s various filings with the Securities and Exchange Commission, including its filing on Form 10-K for the fiscal year ended January 1, 2016, in particular information under the headings “Special Caution Regarding Forward-Looking Statements” and “Risk Factors.”  With regard to the Company’s investment in development-stage enterprises in its Healthcare Innovations segment, there can be no assurance that its operational and developmental objectives will be realized or that the Company’s investments will result in future returns.  The Company undertakes no obligation to update or revise its forward-looking statements.

Almost Family, Inc. Steve Guenthner (502) 891-1000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vobile Teams Up with UNN for AI Factories in Brunei

Updated Category News Views 4

Delving into Vobile's Latest Strategic Move Vobile, a heavyweight in digital content protection based out of Santa Clara, California, has hit the headlines with a new venture. They've inked a strategic cooperation and commercial agreements with Unified National Networks (UNN) of Brunei Darussalam to construct AI factories. This ain't your run-of-the-mill news, folks. It's...

Continue Reading
TriStar Bank Community Room: A Space for Growth

Updated Category News Views 2

Building Bridges Through Community Investment Well, ain't this something? Columbia, Tennessee, just got a splash of fresh air. We're talking about the new Southern Regional Technology Center nested in Columbia State Community College. Now, the name on everyone's lips? The TriStar Bank Community Room. But it ain't just about a name plastered up on a wall inside a shiny...

Continue Reading
AEON's AI-Powered Agentic Checkout: A Game Changer?

Updated Category News Views 6

Cracking the Future: AEON Introduces Agentic Checkout There's a new sheriff in the AI economy: AEON, throwing its hat in the ring with the debut of Agentic Checkout. Now if you think we're just talking about basic automation here, think again. This thing's got its own AI Card that transforms your shopping commands into planned purchases. Think of it as handing over your...

Continue Reading
SIAL West Asia Ignites Global F&B Trade at Guangzhou

Updated Category News Views 3

A Convergence of Global Taste You could feel the buzz in the air as the 2026 SIAL West Asia International Food Exhibition kicked off at the Guangzhou Poly World Trade Center Expo. Throw over 1,500 exhibitors from the far corners of the globe into a sprawling 60,000-square-meter trade floor, and you've got yourself a melting pot of flavors and cultures revolving around a...

Continue Reading
ToolDance X1 CNC Mill Unveils at IFA 2026

Updated Category News Views 1

IFA 2026 Reveals a Game Changer: ToolDance X1 Listen up, because ToolDance just threw a curveball into the CNC world with the launch of their X1 Smart Desktop CNC Mill at the IFA 2026 in Berlin. This isn't just another gadget—it's a real player aiming to bring manufacturing muscle right to your desktop. Will Wang, the genius behind ToolDance, wants to democratize CNC...

Continue Reading
TCL CSOT Dazzles IFA 2026 with Future Display Tech

Updated Category News Views 6

Breaking Ground in Display Technology Picture this: the bustling halls of IFA 2026 in Berlin, teeming with tech enthusiasts and industry leaders. Today marks the start of the grand event where TCL CSOT steps into the spotlight, unveiling a stunning array of next-gen display technologies under the APEX brand. This isn't just another tech show-and-tell; it's TCL’s bold...

Continue Reading
Delisting Gray Wolf Sparks Heated Hunter Nation Debate

Updated Category News Views 2

Unraveling the Gray Wolf Controversy What are we looking at here—political maneuvering wrapped in a fur coat? Trump's executive order is making some calls I didn’t see coming. By pushing to delist the gray wolf from the Endangered Species Act (ESA), he's stirring up a mix of joy, outrage, and a boatload of debate about environmental ethics, conservation priorities,...

Continue Reading
Kate Layman's Dual Board Roles Enhance Community Links

Updated Category News Views 4

Marking Milestones Amid Strategic Shifts What a way to celebrate a two-year anniversary! Kate Layman, founder of M.C. Layman, hits this milestone head-on, not just by steering her company into its third year but also by snagging leadership roles in two significant community organizations in Frederick County, Maryland. You know what's rare today? Executives who don't just...

Continue Reading
UGREEN's AI Hub: Privacy-First Tech for Smart Homes

Updated Category News Views 0

UGREEN's Big AI Leap In the bustling scene of home tech evolution, UGREEN's throwing its hat in the ring with its latest offerings. They've just rolled out the UGREEN HomeAgent series, aiming to redefine what we think of when it comes to smart living. UGREEN, usually known for its tech gadgets, is diving headfirst into the smart home pool. These local AI hubs blend tech...

Continue Reading
Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Updated Category News Views 0

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Continue Reading

Top 5 Most Recently Viewed Articles

Scilex Holding Company Completes Key Steps for Merger

Updated Category News Views 188

Key Announcement from Scilex Holding Company Scilex Holding Company, an innovative player in the pharmaceutical sector, has made significant strides in its ongoing merger processes. The company has announced that the registration statement on Form S-4, related to its proposed business combination with Semnur Pharmaceuticals, has been officially declared effective by the...

Continue Reading
Transforming Government Services with Innovative Solutions

Updated Category News Views 156

Transforming Government Services To usher in modernity in how the government engages with its citizens, Code and Theory has rolled out its Government Experience Practice (GX). This innovative initiative aims to reshape the government's interaction dynamics by leveraging technology and creative solutions. The Vision Behind GX Leading the charge in this transformation is...

Continue Reading
RF Technologies Gears Up for AONL 2025 with Innovative Solutions

Updated Category News Views 167

RF Technologies Set for AONL 2025 Conference RF Technologies is excited to announce its participation in the upcoming AONL Conference. This significant event will occur on March 31 to April 1 at the renowned Boston Convention & Exhibition Center. The company is dedicated to highlighting its key offerings and innovations that enhance healthcare staff protection. About RF...

Continue Reading
LUNGevity Boosts Board with Dr. Michael Gieske Join

Updated Category News Views 6

Champion of Early Detection Joins LUNGevity's Board In a move that raises LUNGevity Foundation's stakes in the fight against lung cancer, they’ve added Dr. Michael Gieske to their Board of Directors. Dr. Gieske comes fully loaded with over thirty years of grit and experience, dedicated to early detection of lung cancer and tireless patient advocacy. Now that’s what I...

Continue Reading
Daxor Corporation Optimizes Regulatory Pathway for Device Launch

Updated Category News Views 300

Daxor Corporation (NASDAQ: DXR) shook things up back in 2024 by revamping its regulatory strategy to fast-track its innovative blood volume analyzer, the BVA-100. They opted for a streamlined 510(k) approval pathway after discussions with the FDA led them to drop a dual application for both 510(k) clearance and CLIA waiver. This move is more than just paperwork—it's...

Continue Reading